<p>BERWYN, Pa., Dec. 05, 2023 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases today anno
The Japanese Yen is facing scrutiny to start the week with USD/JPY edging toward prior peaks on growing unease around potential BoJ intervention. If USD/JPY pops, will the bank be selling?
Leave a Comment